HP
JNJ icon

HealthInvest Partners’s Johnson & Johnson JNJ Stock Holding History

HealthInvest Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.7M Sell
85,425
-6,952
-8% -$1.62M 5.84% 3
2026
Q1 		$11.9M Buy
+92,377
New +$21.5M 3.86% 5

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

HealthInvest Partners's JNJ Position: Q2 2026 in Review

HealthInvest Partners reduced its Johnson & Johnson (JNJ) stake by 7.5% in Q2 2026, selling an estimated $1.62M and leaving 85,425 shares worth $21.7M. The position accounts for 5.84% of the portfolio, ranked #3.

HealthInvest Partners first reported a position in JNJ in Q1 2026 and has held it in 2 quarters since. 1,965 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • HealthInvest Partners held 85,425 shares of Johnson & Johnson worth $21.7M as of Q2 2026.
  • HealthInvest Partners sold 6,952 Johnson & Johnson shares in Q2 2026, an estimated $1.62M.
  • Johnson & Johnson made up 5.84% of HealthInvest Partners's portfolio in Q2 2026, its #3 holding.
  • HealthInvest Partners first reported a position in Johnson & Johnson in Q1 2026 and has held it in 2 quarters since.
  • 1,965 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.